Bloating, Brain Fog, Fatigue: Could SIBO, SIFO, or IMO Be to Blame?

To read this article in French, click here.

Did you know that nearly 60-80% of people with irritable bowel syndrome (IBS) actually have SIBO, but most are never diagnosed?

Chronic digestive issues. Unexplained fatigue. Mood swings. For many, these symptoms have become an unfortunate and persistent part of their lives. But what if these issues weren’t just signs of “a sensitive digestive system”? What if they pointed to an underlying imbalance that affects not only the gut but multiple body systems?

Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methane Overgrowth (IMO), and Small Intestinal Fungal Overgrowth (SIFO) are emerging as hidden culprits behind a range of health issues, yet they remain frequently overlooked. Despite their growing recognition in functional medicine, they often go undiagnosed in conventional settings, leaving patients with conditions that seem inexplicable.

As a functional nutrition practitioner with a focus on immune health, I see how these microbial imbalances wreak havoc, not just on digestion, but on overall wellness. They affect everything from nutrient absorption to immune function and even mental health. What’s worse, many people suffering from these imbalances are never properly tested or diagnosed. Instead, they are left trying to make sense of their symptoms, often misdiagnosed with conditions like IBS or anxiety.

In this article, we’ll explore the complexities of SIBO, IMO, and SIFO, shedding light on how these overgrowths develop, why they are so often missed, and the far-reaching effects they can have on your health. We’ll also dive into the latest diagnostic tools and offer a holistic, integrative approach to managing these conditions—so you can take informed steps toward restoring balance.

I. What is SIBO?

Definition and Mechanism:

Small Intestinal Bacterial Overgrowth (SIBO) occurs when bacteria, typically found in the colon or mouth, proliferate in the small intestine, where they don’t belong. The small intestine is meant to remain relatively sterile to facilitate efficient nutrient absorption. However, when gut motility slows or the body's defenses against bacterial overgrowth weaken, this balance is disrupted.

The resulting bacterial overgrowth impairs digestion and absorption, triggering a cascade of symptoms. Normally, the small intestine serves as the primary site for nutrient absorption, but excess bacteria interfere with this process, leading to both localized and systemic effects.

Research highlights motility disturbances (NB. this does not always mean constipation) as a central driver of SIBO. Conditions like gastroparesis, Irritable Bowel Syndrome (IBS), or scleroderma can slow intestinal transit, creating an environment where bacteria thrive (Pimentel et al., 2000; Camilleri, 2019). Additionally, anatomical abnormalities—such as diverticulosis, surgical adhesions, or intestinal strictures—can form pockets that allow bacterial accumulation, further increasing the risk of overgrowth (Ghoshal et al., 2017).

Digestive Symptoms and Systemic Impact

While digestive distress is the most immediate consequence of SIBO, its effects extend beyond the gut. Key GI symptoms include:

• Bloating and abdominal distension – A sensation of fullness or pressure, often after eating.

• Abdominal pain or discomfort – Ranging from mild cramping to severe pain.

• Diarrhea or constipation – Some individuals experience alternating patterns of both.

• Excess gas production – Belching, burping, and flatulence after meals.

• Indigestion or nausea – An overall feeling of stomach upset, especially post-meal.

Beyond digestive symptoms, malabsorption becomes a major concern. The bacterial overgrowth disrupts nutrient uptake, leading to deficiencies in vitamin B12, iron, and fat-soluble vitamins (A, D, E, K). These deficiencies contribute to fatigue, anemia, and systemic health challenges (Pimentel et al., 2015).

Diagnosing SIBO is complex due to its symptom overlap with a number of other conditions. Many individuals endure chronic symptoms without understanding the underlying cause, leading to frequent misdiagnoses.

II. The High Prevalence of SIBO

How Common is SIBO?

SIBO is far more widespread than many realize, yet it often goes undetected. Research indicates that 60-80% of individuals diagnosed with Irritable Bowel Syndrome (IBS) may actually have SIBO as the underlying cause (Pimentel et al., 2000; Quigley, 2011). However, its prevalence extends beyond IBS—it is also frequently found in individuals with chronic fatigue syndrome, fibromyalgia, and autoimmune diseases such as Hashimoto’s and endometriosis.

Despite its significant occurrence, SIBO remains largely underdiagnosed. One study found that 15-45% of patients with unexplained chronic gastrointestinal symptoms tested positive for SIBO, making it far more common than widely recognized (Bures et al., 2010).

Why is SIBO Often Missed?

Although SIBO affects a substantial portion of the population, it is frequently misdiagnosed or overlooked due to its symptom overlap with other gastrointestinal conditions, including irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), food intolerances, and gluten sensitivity. These disorders share hallmark symptoms such as bloating, abdominal pain, and irregular bowel movements, making it challenging to distinguish SIBO from other digestive issues (Camilleri, 2019).

Another key reason SIBO is underrecognized is the lack of routine testing. Despite its well-established link to digestive distress, healthcare providers do not always include SIBO in standard diagnostic evaluations unless there is a specific clinical suspicion. Lactulose and glucose breath tests, which measure hydrogen and methane gas produced by bacterial fermentation in the small intestine, are not universally used in gastrointestinal workups. Consequently, many individuals suffer from chronic symptoms for years without a definitive diagnosis, leaving the root cause unaddressed.

III. Causes and Risk Factors of SIBO, IMO, and SIFO

The development of Small Intestinal Bacterial Overgrowth (SIBO), Intestinal Methane Overgrowth (IMO), and Small Intestinal Fungal Overgrowth (SIFO) is often driven by factors that disrupt gut balance, including impaired motility and weakened immune defenses. Research continues to expand our understanding of how these conditions overlap.

Reduced Motility

One of the most significant contributors to SIBO and related overgrowths is slowed intestinal motility. Conditions such as gastroparesis, IBS, scleroderma, and diabetes impair the movement of food and waste through the digestive tract, allowing bacteria to remain and proliferate where they shouldn’t. Studies consistently identify motility dysfunction as a primary risk factor for SIBO, as stagnation in the small intestine fosters bacterial overgrowth (Pimentel et al., 2000; Quigley, 2011).

Food Poisoning and GI Infections

A history of food poisoning or gastrointestinal infections is another key precursor. Pathogens like Campylobacter, Salmonella, and Escherichia coli can cause long-term damage to the small intestine, impairing motility, reducing protective secretions such as gastric acid and bile, and altering immune function. Even after acute infections resolve, lingering effects increase SIBO risk. A study by Kruis et al. (2008) linked Campylobacter jejuni infection with a heightened risk of SIBO, underscoring the long-term impact of infections on gut health.

Anatomical Abnormalities and Structural Changes

Gastrointestinal structural abnormalities can also predispose individuals to SIBO and related overgrowths. Diverticulosis, intestinal strictures, and surgical adhesions create pockets where bacteria become trapped and multiply, disrupting normal motility and digestion (Ghoshal et al., 2017).

Hypochlorhydria (Low Stomach Acid)

Stomach acid is a key defense against bacterial overgrowth, and its suppression can facilitate SIBO. Conditions like hypochlorhydria (low stomach acid) or long-term use of proton pump inhibitors (PPIs) significantly reduce stomach acid, allowing bacteria to survive passage through the stomach and colonize the small intestine (Camilleri, 2019). Additionally, Helicobacter pylori (H. pylori) infections can contribute to low stomach acid, as the bacteria interfere with acid production and disrupt the stomach’s natural defense mechanisms. Chronic H. pylori infections not only increase the risk of SIBO but also contribute to broader digestive imbalances.

Mold Toxicity

Exposure to mold is increasingly recognized as a contributing factor to SIBO, IMO, and SIFO. Mold toxins can impair digestion by reducing bile flow, disrupting motility, and altering immune function (Levit et al., 2015). Additionally, they can contribute to leaky gut, fostering dysbiosis—an imbalance in gut bacteria (Haq et al., 2016). Clinically, individuals with mold exposure often present with digestive issues, chronic fatigue, and numerous food sensitivities, with improvements seen when the underlying mold issue is addressed.

Antibiotic Use and Dysbiosis

While antibiotics are crucial for treating infections, they also disrupt the gut microbiome, which plays a critical role in maintaining digestive balance. Frequent or prolonged antibiotic use can deplete beneficial gut bacteria, leading to dysbiosis and increasing the risk of bacterial or fungal overgrowth in the small intestine. Research shows that repeated antibiotic exposure reduces microbial diversity, paving the way for SIBO, IMO, and SIFO (Lutz et al., 2020).

Oral Bacteria and Dysbiosis

Oral health also influences gut health through the oral-gut axis, where bacteria from the mouth may travel to the digestive system. Periodontal disease and dental infections can introduce pathogenic bacteria into the gut, particularly in individuals with gastroesophageal reflux disease (GERD), which facilitates bacterial migration. Studies suggest that chronic dental infections may increase bacterial load in the gut, contributing to SIBO and related conditions (Ghoshal et al., 2019). Maintaining oral hygiene may be a critical yet overlooked factor in preventing gut dysbiosis.

IV. Diagnostic Tools and Challenges

SIBO Testing:

The diagnosis of Small Intestinal Bacterial Overgrowth (SIBO) primarily hinges on breath tests, such as the lactulose and glucose breath tests, which measure the hydrogen and methane gases produced by bacterial fermentation in the small intestine. Elevated gas levels indicate an overgrowth of bacteria, signaling a disruption of normal gut function.

In cases of Intestinal Methane Overgrowth (IMO), breath tests specifically assess methane production, while Small Intestinal Fungal Overgrowth (SIFO) is typically identified through stool analysis to detect fungal pathogens (Pimentel et al., 2015).

A notable advancement in SIBO diagnostics is the TrioSmart breath test, which is capable of detecting Hydrogen Sulfide SIBO (H₂S)—a sulfur-based form of SIBO often associated with severe bloating and discomfort. Previously underdiagnosed by standard breath tests, TrioSmart now offers a vital tool for diagnosing this elusive condition (Pimentel, 2018).

Although breath testing is indispensable, symptom presentation remains paramount in making a diagnosis. Clinicians often integrate clinical findings with test results, and in situations where the results are inconclusive, a trial-based approach—such as antimicrobial treatments or dietary adjustments—can be a practical next step.

Challenges in Diagnosis

Despite their utility, breath tests are not without limitations. False positives may arise, particularly in individuals who are taking probiotics, which can artificially elevate hydrogen levels (Quigley, 2011). Additionally, most breath tests do not detect all forms of SIBO, such as Hydrogen Sulfide SIBO (H₂S), which often goes undiagnosed. While the TrioSmart test has made significant strides in addressing this gap, further advancements in diagnostic techniques are still needed.

Dr. Ruscio’s Approach: A Holistic Perspective

Functional medicine pioneer Dr. Michael Ruscio has redefined the diagnostic process for SIBO and other gut disorders. While traditional testing offers valuable insights, Dr. Ruscio emphasizes clinical intuition and the integration of patient/client history over rigid reliance on laboratory results. His approach champions symptom-driven assessments, which promote more individualized care.

This approach resonates with my own clinical experience. Though testing plays an important role, focusing on a holistic, symptom-based approach really does lead to effective outcomes. When breath tests yield inconclusive results, trial interventions—such as dietary modifications or antimicrobial therapies—can be invaluable in guiding care.

Symptom Presentation vs. Testing

Classic indicators of SIBO can often provide meaningful direction, even when test results are inconclusive. In this context, symptom-based protocols can offer significant relief, allowing for a more flexible, real-time response to a patient/client's needs. This approach gives individuals greater agency over their protocols, empowering them to actively engage in their own care and tailor treatments to their unique experience. It’s a model that emphasizes patient-doctor or client-practitioner partnerships and personalized care, both of which are central to the functional approach.

Studies have shown that up to 50% of people with rosacea have SIBO, with some research suggesting that treating SIBO can improve symptoms.

V. Systemic Effects of SIBO, IMO, and SIFO: Beyond the Gut

The impact of SIBO, IMO, and SIFO extends well beyond digestive distress. Both research and clinical experience have identified a range of systemic effects that affect various organs and bodily systems. Below are some of the most significant:

Nutrient Malabsorption:

SIBO impairs nutrient absorption, particularly for vitamin B12, iron, and fat-soluble vitamins (A, D, E, and K). The overgrowth of bacteria in the small intestine competes with the host for these essential nutrients, leading to deficiencies. This can manifest as fatigue, anemia, and weakness (Pimentel et al., 2015). Additionally, damage to the intestinal villi worsens these deficiencies, impacting overall health, including immune function.

Histamine Intolerance and Immune Dysregulation:

Certain bacteria in the small intestine produce histamine, triggering allergy-like symptoms, headaches, cutaneous eruptions, and anxiety (Schwelger et al., 2020). Damage to the microvilli in the gut impairs the secretion of diamine oxidase (DAO), an enzyme needed to break down histamine. This leads to histamine accumulation and exacerbates symptoms.

Moreover, chronic dysbiosis can impair immune function, leading to increased inflammation and contributing to the development of autoimmune conditions (Zhang et al., 2016). SIBO also blocks nutrients required for methylation, further disrupting histamine breakdown in the brain and central nervous system, which can result in brain fog, insomnia, and irritability.

Iron Dysregulation:

SIBO bacteria tend to compete for iron, exacerbating deficiencies and potentially leading to poor iron absorption, which can then lead to fatigue, weakness, and diminished immune function (Lozupone et al., 2012).

However, treating iron deficiency with supplementation in the presence of SIBO is tricky. While iron is regularly used in conventional medicine to correct “anemia”, it can inadvertently fuel the overgrowth of bacteria that causes the problem, worsening digestive symptoms.

*As an aside, in my experience, “iron deficiency anemia” is usually related to a dysregulation of iron cofactors (specific nutrients, and good digestive function) rather than a true deficiency of iron in the body. Supplementing with iron may provide short-term relief for some, but it doesn’t address the underlying imbalances that are preventing proper iron utilization, and often only increases the body’s inflammatory load.

Methylation Impairment:

Methylation is a key biochemical process that regulates essential functions such as detoxification, gene expression, hormone balance, and immune function. When SIBO disrupts the gut microbiome, it can impair methylation, leading to a build-up of histamine, toxins, hormones, and neurotransmitters, and creating downstream havoc on multiple systems (Jablonski et al., 2020).

Mood Imbalances and the Gut-Brain Axis:

Emerging evidence links SIBO to mood disorders such as anxiety, depression, and brain fog. The gut-brain axis—the communication pathway between the gut and the brain—affects brain chemistry and function. Gut bacteria produce serotonin, a neurotransmitter crucial for mood regulation. When gut bacteria are imbalanced, such as in SIBO, serotonin production can be disrupted, potentially leading to mood issues (Cryan et al., 2013).

Food Sensitivities and Intolerances:

SIBO, IMO, and SIFO are frequently associated with sensitivities to lactose, fructose, gluten, and FODMAPs. FODMAPs (Fermentable Oligo-, Di-, Mono-saccharides and Polyols) are poorly absorbed in the small intestine, and when fermented by gut bacteria, they can cause symptoms. Although, not everyone with SIBO reacts to FODMAPs the same way, and some may tolerate them without issue.

In addition, individuals with these overgrowths may also have sensitivities to sulfur-containing foods and supplements including garlic, onions, cruciferous vegetables, eggs and other protein-rich foods, and supplements such as glutathione, NAC, taurine, . These foods are rich in sulfur, which, when fermented by certain bacteria, produces hydrogen sulfide (H2S) gas. While sulfur itself isn’t inherently problematic, an imbalance in gut bacteria can lead to an overproduction of H2S, contributing to digestive issues.

This overproduction of hydrogen sulfide is particularly relevant in Hydrogen Sulfide SIBO (H2S) and intestinal methane overgrowth (IMO), where H2S-producing bacteria disrupt normal gut function. As a result, individuals with these conditions may experience symptoms similar to food sensitivities, even though the issue stems from a microbial imbalance rather than an intolerance to sulfur.

VI. Therapeutic Approaches for SIBO, IMO, and SIFO

Effectively addressing SIBO, IMO, and SIFO requires a multifaceted approach, incorporating antimicrobial therapies, dietary modifications, gut-healing strategies, and lifestyle interventions. A personalized approach optimizes outcomes and supports long-term gut health.

1. Antimicrobial Treatments

Both herbal antimicrobials—such as oregano oil, garlic, and berberine—and prescription antibiotics like rifaximin (for SIBO) and neomycin (for IMO) are commonly used to reduce bacterial overgrowth (Pimentel et al., 2018). While these treatments alleviate symptoms like bloating and gas, careful selection is critical to avoid further dysbiosis and ensure sustainable gut balance.

2. Dietary Modifications

Diet plays a pivotal role in managing SIBO, IMO, and SIFO. The Low FODMAP diet reduces fermentable carbohydrates, minimizing gas production and bloating (Gibson et al., 2018). Research suggests it not only alleviates symptoms but also aids microbiome restoration (Staudacher et al., 2020). Additionally, studies indicate that a Low FODMAP diet can lower histamine symptoms, making it beneficial for individuals with histamine intolerance often associated with SIBO (Schwelger et al., 2020).

For hydrogen sulfide SIBO, a low-sulfur diet may help, as sulfur-metabolizing bacteria contribute to excessive gas and bloating. Additionally, eliminating common triggers like gluten, lactose, and fructose can further reduce digestive distress.

3. Gut-Healing Supplements

Targeted supplementation supports gut repair and function:

• L-glutamine aids intestinal lining repair.

• Digestive enzymes enhance nutrient absorption.

• Probiotics, once debated in SIBO treatment, now show promise in restoring gut balance. Specific strains such as Lactobacillus, Bifidobacterium, and Saccharomyces boulardii may reduce inflammation and improve treatment efficacy (Lahtinen et al., 2019; Szajewska et al., 2020). Careful strain selection is essential to avoid exacerbating symptoms.

4. Promising New Research

Dr. Mark Pimentel’s research has uncovered a link between anti-vinculin antibodies and persistent cases of SIBO and post-infectious IBS (PI-IBS). These antibodies develop when the immune system attacks vinculin, a protein crucial for gut motility, after exposure to bacterial toxins like CdtB from pathogens such as Campylobacter jejuni.

While often triggered by past infections, these antibodies may also arise from chronic dysbiosis or immune dysfunction, contributing to impaired motility and recurrent bacterial overgrowth. This discovery highlights a potential autoimmune component in SIBO, paving the way for immune-targeted therapies that could improve treatment outcomes for stubborn, relapsing cases.

5. Environmental and Lifestyle Modifications

Addressing root causes is key to preventing recurrence. Mold exposure, for example, can impair bile flow and gut motility, contributing to bacterial and fungal overgrowth (Levit et al., 2015). Eliminating mold sources has significantly improved symptoms in many patients.

Stress, poor sleep, and lack of movement disrupt gut motility and contribute to leaky gut. Incorporating stress management, quality sleep, and regular exercise therefore enhance digestive resilience and support healing.

Since SIBO and related conditions often recur, working with a skilled functional practitioner is essential for identifying underlying drivers and implementing a comprehensive plan. Functional medicine’s root-cause approach reduces recurrence risk and fosters lasting gut health.

Ready to Identify the Root Causes of Your Gut Struggles?

If you’ve been battling persistent digestive issues—whether it’s bloating, gas, fatigue, brain fog, or food sensitivities—you know how frustrating it can be to feel like you’re getting nowhere. You’ve tried different diets, perhaps taken medications, or even undergone tests, yet the answers remain elusive. It’s exhausting and overwhelming—but it doesn’t have to be this way.

Many people knowingly or unknowingly suffering from SIBO, SIFO, or IMO feel stuck in this cycle, unsure of where to turn next.

The truth is, it’s not just about treating symptoms; it’s about identifying the underlying causes and restoring balance to your body as a whole.

If this sounds familiar, The Better Health Bundle is the ideal place to start. This comprehensive assessment will give us a clear picture of your current health status, from your symptoms and health history to any relevant lab results. Together, we’ll create a personalized plan to address the root causes of your gut issues and restore balance—whether it's SIBO, SIFO, or something else entirely. You’ll walk away with actionable insights to take control of your health, and a roadmap to feeling better.

For those of you who already know that your health issues go beyond ‘manageable discomfort’—perhaps you’re struggling with chronic fatigue, autoimmune conditions, or unrelenting digestive distress—Reclaim Your Resilience is a transformative, four-month coaching program designed for those ready to dive deep. Over the course of our time together, I’ll support you in uncovering and addressing the underlying causes of your symptoms, guiding you through a hands-on process that blends nutrition, lifestyle changes, and mindset work. This program is tailored for those ready to reclaim their energy, restore gut function, and address the complex interplay of factors impacting your health.

Whether you’re just beginning to explore the possibility of SIBO or looking for ongoing, in-depth support, these services are designed to meet you where you are and provide you with the tools, guidance, and emotional support you need to regain control of your health.

Don’t settle for a band-aid solution or more unanswered questions. If you’re ready to finally get to the root of your gut health issues, reach out today.

Together, we’ll work toward lasting solutions and help you feel like yourself again!

References:

• Pimentel, M., Chang, C., & Chow, E. (2000). The role of small bowel bacterial overgrowth in irritable bowel syndrome: A systematic review. American Journal of Gastroenterology, 95(4), 982-991.

• Camilleri, M. (2019). Recent advances in the diagnosis and management of irritable bowel syndrome. The Lancet, 393(10174), 888-899.

• Ghoshal, U. C., & Ghoshal, U. (2017). Small intestinal bacterial overgrowth and its diagnosis: A comprehensive review. Digestive Diseases and Sciences, 62(10), 2587-2597.

• Pimentel, M., et al. (2015). Small bowel bacterial overgrowth in the pathogenesis of irritable bowel syndrome. Digestive Diseases and Sciences, 60(10), 2984-2992.

• Quigley, E. M. M. (2011). Small bowel bacterial overgrowth: Clinical features and diagnosis. Journal of Clinical Gastroenterology, 45(5), 411-417.

• Bures, J., Cyrany, J., Kohoutova, D., et al. (2010). Small intestinal bacterial overgrowth syndrome (SIBO): Review article. World Journal of Gastroenterology, 16(21), 2511-2520.

• Kruis, W., et al. (2008). Bacterial overgrowth in patients with Crohn’s disease. European Journal of Clinical Investigation, 38(7), 483-489.

• Levit, R., et al. (2015). Mold exposure and its effects on gut health and immune function. Medical Mycology, 53(2), 195-201.

• Haq, M. Z., et al. (2016). Mold toxins and gut permeability: A potential link to chronic digestive issues. Journal of Environmental Science and Health, 54(6), 1126-1133.

• Lutz, H. M., et al. (2020). Impact of antibiotics on gut microbiota and its role in bacterial overgrowth. Clinical Microbiology Reviews, 33(1), e00011-19.

• Cryan, J. F., & Dinan, T. G. (2013). Mind-altering microorganisms: The impact of the gut microbiota on brain and behavior. Nature Reviews Neuroscience, 13(10), 701-712.

• Mayer, E. A. (2011). Gut feelings: The emerging biology of gut-brain communication. Nature Reviews Neuroscience, 12(9), 453-466.

• Whelan, K., et al. (2011). The low FODMAP diet: A comprehensive approach to managing symptoms of IBS. Journal of Gastroenterology and Hepatology, 26(4), 600-608.

• Gibson, P. R., et al. (2018). The Low FODMAP diet for the management of irritable bowel syndrome and functional gastrointestinal disorders. Gastroenterology, 154(5), 1282-1294.

• Jablonski, M., et al. (2020). Methylation and its impact on gut health. Frontiers in Nutrition, 7, 91.

• Lozupone, C. A., et al. (2012). Diversity, stability, and resilience of the human gut microbiome. Nature, 489(7415), 220-230.

• Schwelger, S., et al. (2020). Histamine intolerance and its association with gut dysbiosis. Journal of Clinical Gastroenterology, 54(1), 56-63.

• Zhang, Z., et al. (2016). Gut dysbiosis in the pathogenesis of autoimmune diseases. European Journal of Clinical Investigation, 46(7), 537-547.

• Pimentel, M. (2018). Hydrogen sulfide as a pathogenic mediator in SIBO and IBS. Current Gastroenterology Reports, 20(10), 58.

• Pimentel, M., et al. (2019). Probiotic treatment in SIBO patients: Scientific insights and clinical findings. American Journal of Gastroenterology, 114(1), 87-95.

• Ruscio, M. (2020). Functional medicine and gut health: Improving patient care with root cause analysis. Integrative Medicine: A Clinician's Journal, 19(4), 32-38.